Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (7) , 1002-1007
- https://doi.org/10.1016/0959-8049(94)90132-5
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service (5ROlCA14054)
- National Institutes of Health
This publication has 24 references indexed in Scilit:
- P glycoprotein (P-gp) and drug resistance – time for reappraisal?British Journal of Cancer, 1993
- MDR1 (p-glycoprotein) Gene Expression--Implications for Resistance Modifier TrialsJNCI Journal of the National Cancer Institute, 1992
- Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristineEuropean Journal of Cancer and Clinical Oncology, 1991
- Multidrug resistance from the clinical point of viewEuropean Journal of Cancer and Clinical Oncology, 1991
- Expression of P-glycoprotein in epithelial ovarian cancer: Evaluation as a marker of multidrug resistanceAmerican Journal of Obstetrics and Gynecology, 1990
- Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.Journal of Clinical Oncology, 1990
- Detection of drug resistance in human ovarian carcinomaArchiv für Gynäkologie, 1989
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985